1159512-68-1

Basic information

• Product Name: 1-BROMO-4-BROMOMETHYL-2-TRIFLUOROMETHYL-BENZENE
• Synonyms: 1-BROMO-4-BROMOMETHYL-2-TRIFLUOROMETHYL-BENZENE;4-Bromo-3-(trifluoromethyl)benzyl bromide;1-Bromo-4-(bromomethyl)-2-(trifluoromethyl)benzene, 2-Bromo-5-(bromomethyl)benzotrifluoride
• CAS NO: 1159512-68-1
• Molecular Formula: C₈H₅Br₂F₃
• Molecular Weight: 317.93
• Mol File: 1159512-68-1.mol

Chemical Properties

• Boiling Point: 250.7±35.0 °C(Predicted)
• Appearance: /
• Density: 1.885±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1-BROMO-4-BROMOMETHYL-2-TRIFLUOROMETHYL-BENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BROMO-4-BROMOMETHYL-2-TRIFLUOROMETHYL-BENZENE(1159512-68-1)
• EPA Substance Registry System: 1-BROMO-4-BROMOMETHYL-2-TRIFLUOROMETHYL-BENZENE(1159512-68-1)

Safety Data

• Hazardous Substances Data: 1159512-68-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
1-BROMO-4-BROMOMETHYL-2-TRIFLUOROMETHYL-BENZENE is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals, contributing to the development of new drugs and pesticides. Its presence in these compounds is crucial for their therapeutic or pesticidal properties.
Used in Organic Synthesis:
As a reagent, 1-BROMO-4-BROMOMETHYL-2-TRIFLUOROMETHYL-BENZENE is utilized in organic synthesis processes, facilitating the formation of complex organic molecules through its reactive bromine and trifluoromethyl groups.
Used in Specialty Chemicals and Materials Production:
1-BROMO-4-BROMOMETHYL-2-TRIFLUOROMETHYL-BENZENE serves as a building block in the production of specialty chemicals and materials, where its unique structure imparts specific properties to the final products, enhancing their performance and applications.
Used in Organic Electronics and Photovoltaics:
Due to its electronic properties, 1-BROMO-4-BROMOMETHYL-2-TRIFLUOROMETHYL-BENZENE has potential applications in the field of organic electronics and photovoltaics, where it can be employed to improve the efficiency and functionality of electronic devices and solar cells.

Upstream product

• 957207-09-9 (4-bromo-3-(trifluoromethyl)phenyl)methanol 
• 261952-20-9 1-bromo-4-methyl-2-(trifluoromethyl)benzene 
• 107317-58-8 4-bromo-3-trifluoromethylbenzoic acid methyl ester 
• 161622-14-6 4-bromo-3-(trifluoromethyl)benzoic acid 

Downstream Products

• 800379-62-8 O-(4-cyclohexyl-3-trifluoromethyl-benzyl)-hydroxylamine 

Relevant articles and documents

Intermediate of siponimod and synthesis method thereof

The invention relates to a novel intermediate compound (a compound as shown in a formula 2A) of siponimod, a synthesis method of the novel intermediate compound, and a method for synthesizing siponimod by adopting the compound as shown in the formula 2A. Specifically, 3-trifluoromethyl-4-halogenated benzoic acid or 3-trifluoromethyl-4-halogenated toluene is taken as an initial raw material and is subjected to reduction, bromination, coupling, substitution and reduction to obtain a compound as shown in a formula 2A, and R is Boc or Ac.

AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE

Relating to a compound represented by formula (I) and a pharmaceutically acceptable salt of the compound, and an application of the compound as an S1P1 agonist.

Modulators of the nuclear hormone receptor ROR

The invention provides small molecule modulators of retinoic acid receptor-related orphan receptors such as RORα, RORβ, or RORγ, of formula with the variable atoms as defined herein and R1 comprising a hydroxyl- or alkoxyl-substituted fluoroalkyl group. Compounds of the invention can be effective modulators at concentrations ineffective to act on LXR receptors, or on other nuclear receptors, or other biological targets. Methods of modulation the RORs and methods of treating metabolic disorders, immune disorders, cancer, and CNS disorders wherein modulation of an ROR is medically indicated are also provided.

SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES

The present invention relates to polysubstituted imidazolone derivatives, to the pharmaceutical compositions comprising them and to the therapeutic uses thereof in the human and animal health fields. The present invention also relates to a process for preparing these derivatives.